ArticleInternational journal of molecular sciences2026
Chronic Administration of Marinobufagenin in Mice Causes Hyperlocomotion and Decrease in Anxiety by Altering Monoamine Turnover Unaccompanied by Motor Deficits or Oxidative Stress.
Rogneda B Kazanskaya et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.